- Nachrichtendetail
-
12.02.2024 19:00:35 - dpa-AFX: EQS-News: Medacta to Feature GMK SpheriKA and Innovative Personalized Solutions at AAOS 2024 (english)
Medacta to Feature GMK SpheriKA and Innovative Personalized Solutions at
AAOS 2024
Medacta Group SA / Key word(s): Miscellaneous
Medacta to Feature GMK SpheriKA and Innovative Personalized Solutions at
AAOS 2024
12.02.2024 / 19:00 CET/CEST
---------------------------------------------------------------------------
MEDIA RELEASE
Medacta to Feature GMK SpheriKA and Innovative Personalized Solutions at
AAOS 2024
CASTEL SAN PIETRO, 12 February 2024 - Medacta Group SA ('Medacta',
SIX:MOVE), a Swiss company specializing in the design, production, and
distribution of innovative, personalized, and sustainable solutions for
joint replacement, sports medicine, and spine surgeries, is pleased to
announce its participation in the 2024 American Association of Orthopaedic
Surgeons (AAOS) Annual Meeting in San Francisco, CA from February 12-16,
2024, booth 1845, to learn about GMK SpheriKA, the world's first
KA-optimized femoral component indicated for total knee replacement and
Medacta's innovative offerings.
'Improving patient outcomes with innovative and sustainable solutions is our
highest priority at Medacta,' stated Francesco Siccardi, Chief Executive
Officer of Medacta. 'As we mark our 25th anniversary, we are proud to
introduce the GMK SpheriKA, an implant and a surgical technique that is
gaining a lot of attention and that could become the new gold standard in
the future of Total Knee Replacement.'
Attendees will have the opportunity to learn more about GMK SpheriKA. Built
upon the legacy of the GMK Sphere's ball-in-socket design, GMK SpheriKA
offers patients an implant that potentially feels more natural and stable
during daily activities, replicating the movement of the healthy knee. GMK
SpheriKA is the world's first knee system specifically designed based on the
principles of Kinematic Alignment, which allows surgeons to accommodate
better optimal patella tracking in a wider range of patients.
As part of its focus on GMK SpheriKA, Medacta is also a sponsor of the AAOS
2024 OrthoDome session on Thursday, February 12, during which surgeons will
have the opportunity to view 'Calipered Kinematic Alignment with the World's
First KA-Optimized Knee System.' During this procedure, Stephen Howell, MD,
from Lodi, CA will perform a total knee arthroplasty on a varus knee
utilizing GMK SpheriKA.
'I am excited for the opportunity to share the GMK SpheriKA technique with
AAOS attendees,' said Stephen Howell, MD. 'As the world's first KA-optimized
knee implant, GMK SpheriKA represents a tremendous step forward in
delivering personalized patient care and returning patients to their
everyday activities more quickly.'
In addition, Medacta will showcase the NextAR Augmented Reality Surgical
Platform, which leverages patient-specific, unique, real-time data to
complement operative workflow efficiently. Through advanced 3D planning
tools, a revolutionary and proprietary single-use tracking system, and
augmented reality, NextAR enables data-driven decision-making, allowing
surgeons to perform personalized procedures based on each patient's unique
anatomy and biomechanics. NextAR is offered as a hardware system with
limited capital investment and single-use instrumentation at a low cost per
case and offers the ability to host software for multiple applications.
NextAR is part of the MySolutions Personalized Ecosystem, a network of
advanced digital solutions designed to improve patient outcomes and
healthcare efficiency during the entire episode of care.
All Medacta products, including GMK SpheriKA and NextAR, are supported by
the comprehensive, tailored educational offerings provided by the M.O.R.E.
Institute. With an international network of expert surgeons, the M.O.R.E.
Institute is at the forefront of education with personalized, high-level
educational pathways. With Medacta, the surgeon is never alone.
Contact
Medacta International SA
Gianluca Olgiati
Senior Director Global Marketing
Phone: +41 91 696 60 60
media@medacta.ch
ABOUT MEDACTA
Medacta is an international company specializing in the design, production,
and distribution of innovative orthopaedic products, as well as in the
development of accompanying surgical techniques. Established in 1999 in
Switzerland, Medacta is active in joint replacement, spine surgery, and
sports medicine. Medacta is committed to improving the care and well-being
of patients and maintains a strong focus on healthcare sustainability.
Medacta's innovation, forged by close collaboration with surgeon experts
globally, began with minimally invasive surgical techniques and has evolved
into personalized solutions for every patient. Through the M.O.R.E.
Institute, Medacta supports surgeons with a comprehensive and tailored
program dedicated to the advancement of medical education. Medacta is
headquartered in Castel San Pietro, Switzerland, and operates in over 50
countries. Follow us on Medacta TV, YouTube, LinkedIn, and X.
RELATED TRADEMARKS
Medacta Group Related Trademarks are registered at least in Switzerland. The
products and services listed below may not be all-inclusive, and other
Medacta products and services not listed below may be covered by one or more
trademarks. The below products and services may be covered by additional
trademarks not listed below. Note that Swiss trademarks may have foreign
counterparts. GMK® SpheriKA, NextARTM, MySolutionsTM Personalized Ecosystem.
---------------------------------------------------------------------------
Additional features:
File: https://eqs-cockpit.com/c/fncls.ssp?u=aa36c15608aae84d1c66e4ea5047c898
File description: Medacta to Feature GMK SpheriKA and Innovative
Personalized Solutions at AAOS 2024
---------------------------------------------------------------------------
End of Media Release
---------------------------------------------------------------------------
End of News EQS News Service
---------------------------------------------------------------------------
1835461 12.02.2024 CET/CEST
AAOS 2024
Medacta Group SA / Key word(s): Miscellaneous
Medacta to Feature GMK SpheriKA and Innovative Personalized Solutions at
AAOS 2024
12.02.2024 / 19:00 CET/CEST
---------------------------------------------------------------------------
MEDIA RELEASE
Medacta to Feature GMK SpheriKA and Innovative Personalized Solutions at
AAOS 2024
CASTEL SAN PIETRO, 12 February 2024 - Medacta Group SA ('Medacta',
SIX:MOVE), a Swiss company specializing in the design, production, and
distribution of innovative, personalized, and sustainable solutions for
joint replacement, sports medicine, and spine surgeries, is pleased to
announce its participation in the 2024 American Association of Orthopaedic
Surgeons (AAOS) Annual Meeting in San Francisco, CA from February 12-16,
2024, booth 1845, to learn about GMK SpheriKA, the world's first
KA-optimized femoral component indicated for total knee replacement and
Medacta's innovative offerings.
'Improving patient outcomes with innovative and sustainable solutions is our
highest priority at Medacta,' stated Francesco Siccardi, Chief Executive
Officer of Medacta. 'As we mark our 25th anniversary, we are proud to
introduce the GMK SpheriKA, an implant and a surgical technique that is
gaining a lot of attention and that could become the new gold standard in
the future of Total Knee Replacement.'
Attendees will have the opportunity to learn more about GMK SpheriKA. Built
upon the legacy of the GMK Sphere's ball-in-socket design, GMK SpheriKA
offers patients an implant that potentially feels more natural and stable
during daily activities, replicating the movement of the healthy knee. GMK
SpheriKA is the world's first knee system specifically designed based on the
principles of Kinematic Alignment, which allows surgeons to accommodate
better optimal patella tracking in a wider range of patients.
As part of its focus on GMK SpheriKA, Medacta is also a sponsor of the AAOS
2024 OrthoDome session on Thursday, February 12, during which surgeons will
have the opportunity to view 'Calipered Kinematic Alignment with the World's
First KA-Optimized Knee System.' During this procedure, Stephen Howell, MD,
from Lodi, CA will perform a total knee arthroplasty on a varus knee
utilizing GMK SpheriKA.
'I am excited for the opportunity to share the GMK SpheriKA technique with
AAOS attendees,' said Stephen Howell, MD. 'As the world's first KA-optimized
knee implant, GMK SpheriKA represents a tremendous step forward in
delivering personalized patient care and returning patients to their
everyday activities more quickly.'
In addition, Medacta will showcase the NextAR Augmented Reality Surgical
Platform, which leverages patient-specific, unique, real-time data to
complement operative workflow efficiently. Through advanced 3D planning
tools, a revolutionary and proprietary single-use tracking system, and
augmented reality, NextAR enables data-driven decision-making, allowing
surgeons to perform personalized procedures based on each patient's unique
anatomy and biomechanics. NextAR is offered as a hardware system with
limited capital investment and single-use instrumentation at a low cost per
case and offers the ability to host software for multiple applications.
NextAR is part of the MySolutions Personalized Ecosystem, a network of
advanced digital solutions designed to improve patient outcomes and
healthcare efficiency during the entire episode of care.
All Medacta products, including GMK SpheriKA and NextAR, are supported by
the comprehensive, tailored educational offerings provided by the M.O.R.E.
Institute. With an international network of expert surgeons, the M.O.R.E.
Institute is at the forefront of education with personalized, high-level
educational pathways. With Medacta, the surgeon is never alone.
Contact
Medacta International SA
Gianluca Olgiati
Senior Director Global Marketing
Phone: +41 91 696 60 60
media@medacta.ch
ABOUT MEDACTA
Medacta is an international company specializing in the design, production,
and distribution of innovative orthopaedic products, as well as in the
development of accompanying surgical techniques. Established in 1999 in
Switzerland, Medacta is active in joint replacement, spine surgery, and
sports medicine. Medacta is committed to improving the care and well-being
of patients and maintains a strong focus on healthcare sustainability.
Medacta's innovation, forged by close collaboration with surgeon experts
globally, began with minimally invasive surgical techniques and has evolved
into personalized solutions for every patient. Through the M.O.R.E.
Institute, Medacta supports surgeons with a comprehensive and tailored
program dedicated to the advancement of medical education. Medacta is
headquartered in Castel San Pietro, Switzerland, and operates in over 50
countries. Follow us on Medacta TV, YouTube, LinkedIn, and X.
RELATED TRADEMARKS
Medacta Group Related Trademarks are registered at least in Switzerland. The
products and services listed below may not be all-inclusive, and other
Medacta products and services not listed below may be covered by one or more
trademarks. The below products and services may be covered by additional
trademarks not listed below. Note that Swiss trademarks may have foreign
counterparts. GMK® SpheriKA, NextARTM, MySolutionsTM Personalized Ecosystem.
---------------------------------------------------------------------------
Additional features:
File: https://eqs-cockpit.com/c/fncls.ssp?u=aa36c15608aae84d1c66e4ea5047c898
File description: Medacta to Feature GMK SpheriKA and Innovative
Personalized Solutions at AAOS 2024
---------------------------------------------------------------------------
End of Media Release
---------------------------------------------------------------------------
Language: English
Company: Medacta Group SA
Strada Regina
6874 Castel San Pietro
Switzerland
Phone: +41 91 696 6060
E-mail: info@medacta.ch
Internet: www.medacta.com
ISIN: CH0468525222
Listed: SIX Swiss Exchange
EQS News ID: 1835461
End of News EQS News Service
---------------------------------------------------------------------------
1835461 12.02.2024 CET/CEST
